New wearable device could ease lymphedema for breast cancer survivors

NCT ID NCT04908254

First seen Jan 04, 2026 · Last updated Apr 29, 2026 · Updated 22 times

Summary

This study tested a new wearable compression device (Dayspring) against a standard pneumatic device for treating lymphedema in 50 adults with breast cancer-related arm swelling. The goal was to see if the wearable device is safe and effective at reducing swelling and improving quality of life. Participants used both devices in a crossover design, and researchers measured arm volume and patient-reported outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LYMPHEDEMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Ginger-K Lymphedema & Cancer Center

    Morgan Hill, California, 95037, United States

  • PT works

    Los Altos, California, 94024, United States

Conditions

Explore the condition pages connected to this study.